Abdominal Burkitt-type lymphomas in Algeria
Author Information
Author(s): Y. Ladjadj, T. Philip, G.M. Lenoir, F.Z. Tazerout, K. Bendisari, R. Boukheloual, P. Biron, M. Brunat-Mentigny, M. Aboulola
Primary Institution: Clinique de Chirurgie Pediatrique, CHU Mustapha, Algiers, Algeria
Hypothesis
Burkitt-type lymphomas account for a significant percentage of childhood non-Hodgkin's lymphomas in Algeria.
Conclusion
The study found that Burkitt-type lymphomas are prevalent in Algerian children, with a notable survival rate for those achieving complete remission.
Supporting Evidence
- Burkitt-type lymphomas accounted for around 46.5% of childhood non-Hodgkin's lymphomas in Algeria.
- Complete remission was achieved in 61% of patients.
- Overall survival rate was 42.85% for the group studied.
- 88% of the studied cases were associated with Epstein-Barr virus.
- The age distribution showed a peak incidence between 4 and 5 years.
Takeaway
This study looked at children in Algeria with a type of cancer called Burkitt lymphoma, finding that many of them can get better with treatment, especially if they respond well to the first round of medicine.
Methodology
The study involved a retrospective analysis of 49 cases of abdominal Burkitt-type lymphomas treated at a pediatric clinic in Algeria, including surgical and chemotherapy treatments.
Limitations
The study's conclusions may be limited by the small sample size and the specific geographic focus on Algeria.
Participant Demographics
The participants included 34 males and 15 females, with a peak age of 4 to 5 years.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website